Published on 4/13/2018 in the Prospect News Structured Products Daily.
New Issue: Credit Suisse sells $665,000 contingent coupon callable yield notes on index, ETF
By Wendy Van Sickle
Columbus, Ohio, April 13 – Credit Suisse AG, London Branch priced $665,000 of contingent coupon callable yield notes due April 17, 2023 linked to the S&P 500 index and the SPDR S&P Biotech ETF, according to a 424B2 filed with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon of 8.55% per year unless either asset closes below its 60% coupon barrier on the observation date that quarter.
The payout at maturity will be par unless either asset finishes below its 60% knock-in level, in which case investors will lose 1% for each 1% decline of the worse performing asset.
The notes will be callable at par on any quarterly call date beginning April 16, 2020.
Credit Suisse Securities (USA) LLC is the agent.
Issuer: | Credit Suisse AG, London Branch
|
Issue: | Contingent coupon callable yield notes
|
Underlying assets: | S&P 500 index and SPDR S&P Biotech ETF
|
Amount: | $665,000
|
Maturity: | April 17, 2023
|
Coupon: | 8.55% per year, payable quarterly unless either asset closes below coupon barrier on observation date that quarter
|
Price: | Par of $1,000
|
Payout at maturity: | Par unless any either finishes below knock-in level, in which case 1% loss for each 1% decline of worse performing asset
|
Call option: | At par on any quarterly call date after one year
|
Initial levels: | 1,579.303 for S&P, $89.15 for biotech ETF
|
Coupon barriers: | 1,585.314 for S&P, $53.49 for biotech ETF; 60% of initial levels
|
Knock-in levels: | 1,585.314 for S&P, $53.49 for biotech ETF; 60% of initial levels
|
Pricing date: | April 11
|
Settlement date: | April 16
|
Agent: | Credit Suisse Securities (USA) LLC
|
Fees: | 1.075%
|
Cusip: | 22550WP68
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.